Dynamic Tumor-Specific MHC-II Immuno-PET Predicts Checkpoint Inhibitor Immunotherapy Efficacy in Melanoma
Z Yang, F Li, Y Huang, N Yin, J Chu, Y Ma… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Despite the advance of immunotherapy, only a small subset of patients gains long-term
survival benefit. It warrants a compelling rationale to develop immuno-PET imaging that …
survival benefit. It warrants a compelling rationale to develop immuno-PET imaging that …
Dynamic Tumor-Specific MHC-II Immuno-PET Predicts the Efficacy of Checkpoint Inhibitor Immunotherapy in Melanoma
Z Yang, F Li, Y Huang, N Yin, J Chu, Y Ma… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Despite the advance of immunotherapy, only a small subset of patients gains long-term
survival benefit. This fact represents a compelling rationale to develop immuno-PET imaging …
survival benefit. This fact represents a compelling rationale to develop immuno-PET imaging …
[HTML][HTML] Predictive value and accuracy of [18F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma
N Ayati, Z Jamshidi-Araghi, M Hoellwerth… - European Journal of …, 2023 - Springer
Abstract Purpose Immune checkpoint inhibitors (ICIs) are widely used in metastatic
melanoma and dramatically alter the treatment of these patients. Given the high cost and …
melanoma and dramatically alter the treatment of these patients. Given the high cost and …
[HTML][HTML] Improved survival prediction by combining radiological imaging and S-100B levels into a multivariate model in metastatic melanoma patients treated with …
Purpose: We explored imaging and blood bio-markers for survival prediction in a cohort of
patients with metastatic melanoma treated with immune checkpoint inhibition. Materials and …
patients with metastatic melanoma treated with immune checkpoint inhibition. Materials and …
Predictive value and accuracy of PET modified response criteria for immunotherapy in patients with advanced melanoma
Z Jamshidi, M Hoellwerth, W Hitzl, P Koelblinger… - 2022 - Soc Nuclear Med
2494 Introduction: Immune checkpoint inhibitors (ICIs) are widely used in metastatic
malignant melanoma and dramatically alter the treatment of patients with advanced or …
malignant melanoma and dramatically alter the treatment of patients with advanced or …
Prediction of response to immune checkpoint inhibitor therapy using early-time-point 18F-FDG PET/CT imaging in patients with advanced melanoma
The purpose of this study was to evaluate 18F-FDG PET/CT scanning as an early predictor
of response to immune checkpoint inhibitors (ICIs) in patients with advanced melanoma …
of response to immune checkpoint inhibitors (ICIs) in patients with advanced melanoma …
Comparison of 18F-FDG PET/CT criteria for the prediction of therapy response and clinical outcome in patients with metastatic melanoma treated with ipilimumab and …
A Annovazzi, S Vari, D Giannarelli… - Clinical Nuclear …, 2020 - journals.lww.com
Immunotherapy currently represents one of the most effective therapies in metastatic
melanoma. However, its indirect antineoplastic activity through the immune system has …
melanoma. However, its indirect antineoplastic activity through the immune system has …
235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
Background Favorable outcomes utilizing anti–PD-1 based immune therapies for
unresectable melanoma patients are hypothesized to be dependent on antigen processing …
unresectable melanoma patients are hypothesized to be dependent on antigen processing …
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
FK Krebs, ER Trzeciak, S Zimmer… - Cancer …, 2021 - Wiley Online Library
Background Malignant melanoma is an immunogenic skin cancer with an increasing global
incidence. Advanced stages of melanoma have poor prognoses. Currently, there are no …
incidence. Advanced stages of melanoma have poor prognoses. Currently, there are no …
18F-FDG PET/CT for monitoring of ipilimumab therapy in patients with metastatic melanoma
Immune checkpoint inhibitors (ICIs) are now commonly used to treat patients with metastatic
malignant melanoma. Although concerns have been raised that the inflammatory response …
malignant melanoma. Although concerns have been raised that the inflammatory response …